AtriCure Reports Second Quarter 2018 Financial Results

Go back to AtriCure Reports Second Quarter 2018 Financial Results

AtriCure Inc. (ATRC) PT Raised to $30 at Northland Capital Markets

August 2, 2018 1:30 PM EDT

Northland Capital Markets raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $30.00 (from $25.00) while maintaining an Outperform rating.

Analyst Suraj Kalia commented, "Atricure' Q2-18 revenues of $51.8M were roughly in-line with our estimate @ $50.8M. Appendage mgmt continues to be... More

AtriCure Inc. (ATRC) PT Raised to $36 at Needham & Company

August 2, 2018 6:31 AM EDT

Needham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $36.00 (from $32.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "ATRC's 2Q18 revenue accelerated to 13.5% vs. 12.0% in 1Q18 and beat consensus. Management raised its 2018 revenue guidance to $193-197M... More

AtriCure (ATRC) Tops Q2 EPS by 22c

August 1, 2018 4:38 PM EDT

AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.01), $0.22 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $49.9 million.

GUIDANCE:

AtriCure sees FY2018 revenue of $193-197 million, versus the consensus of $195... More